Clinical trial
Glycemic Relapse Prevention: Maintenance Dose Assessment
NCT00362193 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00362193 |
|---|---|
| Title | Glycemic Relapse Prevention: Maintenance Dose Assessment |
| Official title | Longitudinal Diabetes Care: A Randomized Controlled Trial to Prevent Glycemic Relapse |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Vanderbilt University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Behavioral |
| Interventions | Telephonic diabetes care |
| Enrollment | 165 |
| Start date | Jun 1, 2002 |
| Completion | Feb 1, 2007 |
| First posted | Aug 9, 2006 |
| Last update posted | Feb 15, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: